We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Laura Cappelli MD, MHS

Laura C. Cappelli MD, MHS

Assistant Professor of Medicine and Oncology, Johns Hopkins School of Medicine, Division of Rheumatology, Baltimore, MD

Dr. Laura C. Cappelli is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine and Oncology in the Division of Rheumatology, and a faculty member of the Johns Hopkins Arthritis Center. She earned her M.D. from Johns Hopkins. She completed her residency in internal medicine and fellowship in rheumatology at the Johns Hopkins Hospital. Dr. Cappelli also obtained an MHS in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Her primary research focus is rheumatologic adverse effects of cancer immunotherapy including the clinical characteristics, epidemiology, impact on patients, and biologic mechanisms of these adverse events. Dr. Cappelli co-chairs the Immune Related Toxicity Team at Johns Hopkins. In addition, she studies rheumatoid arthritis, focusing on patients with seronegative disease and on the use of autoantibodies as biomarkers.

Disclosures

No relevant disclosures reported.